News

[July 1, 2025] Plumino Precision Fermentation Holdings Pte. Ltd. (hereinafter the “Plumino Group”), an emerging synthetic biology platform with deep industrial expertise in microbial fermentation and a strategic focus on pharmaceutical ingredients and nutritional health solutions, today announced the successful completion of its acquisition of the amino acids and Human Milk Oligosaccharides (“HMOs”) businesses of Kyowa Hakko Bio Co., Ltd. (hereinafter “Kyowa Hakko Bio”).

On April 30, 2025, Plumino, a new enterprise dedicated to becoming a global leader in the amino acid sector, officially announced its establishment. Plumino will deliver core value to customers worldwide through its exceptional high-quality amino acid products and comprehensive professional solutions across all categories.